We are live on ! Find out more
BL

Balentine LLC Portfolio holdings

AUM $2.48B
1-Year Est. Return 17.44%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+17.44%
3 Year Est. Return
+46.33%
5 Year Est. Return
+51.14%
10 Year Est. Return
+189.48%
AUM
$1.02B
AUM Growth
+$71M
Cap. Flow
+$25.8M
Cap. Flow %
2.52%
Top 10 Hldgs %
92.79%
Holding
621
New
116
Increased
174
Reduced
62
Closed
36

Top Buys

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$9.24M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$5.06M
3
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$3.79M
4
QCOM icon
Qualcomm
QCOM
+$1.79M
5
VONV icon
Vanguard Russell 1000 Value ETF
VONV
+$1.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$438K
2
WY icon
Weyerhaeuser
WY
+$424K
3
REG icon
Regency Centers
REG
+$352K
4
IDXX icon
Idexx Laboratories
IDXX
+$266K
5
BFH icon
Bread Financial
BFH
+$251K

Sector Composition

Rank Sector Weight
1 Technology 2.35%
2 Financials 1.49%
3 Consumer Staples 1.44%
4 Energy 1.34%
5 Industrials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFPI icon
526
UFP Industries
UFPI
$4.97B
$3K ﹤0.01%
+90
New +$3.01K
UL icon
527
Unilever
UL
$131B
$3K ﹤0.01%
48
+4
+9% +$202
USO icon
528
United States Oil Fund
USO
$2.45B
$3K ﹤0.01%
38
– –
WBS icon
529
Webster Financial
WBS
$12.3B
$3K ﹤0.01%
+61
New +$3.26K
XLNX
530
DELISTED
Xilinx Inc
XLNX
$3K ﹤0.01%
+59
New +$3.47K
EV
531
DELISTED
Eaton Vance Corp.
EV
$3K ﹤0.01%
+64
New +$2.84K
MDSO
532
DELISTED
Medidata Solutions, Inc.
MDSO
$3K ﹤0.01%
+45
New +$2.43K
SGYP
533
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$3K ﹤0.01%
559
– –
TSRO
534
DELISTED
TESARO, Inc.
TSRO
$3K ﹤0.01%
+21
New +$3.42K
CAA
535
DELISTED
CalAtlantic Group, Inc.
CAA
$3K ﹤0.01%
+71
New +$2.51K
CEB
536
DELISTED
CEB Inc.
CEB
$3K ﹤0.01%
+40
New +$3.08K
BCR
537
DELISTED
CR Bard Inc.
BCR
$3K ﹤0.01%
+12
New +$2.89K
AA icon
538
Alcoa
AA
$11.7B
$2K ﹤0.01%
+47
New +$1.65K
AIG icon
539
American International
AIG
$41.9B
$2K ﹤0.01%
+37
New +$2.38K
AVXL icon
540
Anavex Life Sciences
AVXL
$222M
$2K ﹤0.01%
280
– –
BIO icon
541
Bio-Rad Laboratories Class A
BIO
$8.42B
$2K ﹤0.01%
+12
New +$2.31K
CNS icon
542
Cohen & Steers
CNS
$4.18B
$2K ﹤0.01%
+60
New +$2.17K
DOV icon
543
Dover
DOV
$27.2B
$2K ﹤0.01%
+30
New +$1.91K
EHC icon
544
Encompass Health
EHC
$11.2B
$2K ﹤0.01%
50
– –
GBCI icon
545
Glacier Bancorp
GBCI
$6.55B
$2K ﹤0.01%
+53
New +$1.88K
HEI.A icon
546
HEICO Corp Class A
HEI.A
$35.4B
$2K ﹤0.01%
+55
New +$1.97K
HELE icon
547
Helen of Troy
HELE
$663M
$2K ﹤0.01%
+18
New +$1.7K
IPG
548
DELISTED
Interpublic Group of Companies
IPG
$2K ﹤0.01%
83
– –
IWF icon
549
iShares Russell 1000 Growth ETF
IWF
$122B
$2K ﹤0.01%
56
– –
MD icon
550
Pediatrix Medical
MD
$2.16B
$2K ﹤0.01%
+32
New +$2.22K
20 21
22
23 24

Similar funds

FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
JC
JB Capital Wethersfield, Connecticut $2.48B AUM 22.31% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

Balentine LLC's Q1 2017 Portfolio in Review

As of Q1 2017, Balentine LLC held 621 positions worth $1.02B, up 7.5% from $952M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Balentine LLC's Q1 2017 filing shows 116 new, 174 increased, 62 reduced and 36 closed positions. Its largest new stake was National Commerce Corporation: 20,608 shares worth $754K. The largest sale was Ventas, an estimated $438K.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2.1% a quarter earlier, followed by Financials and Consumer Staples.

  • Balentine LLC's largest Q1 2017 buy was National Commerce Corporation: 20,608 shares worth $754K.
  • Balentine LLC added most to iShares MSCI ACWI ETF in Q1 2017, an estimated $9.24M increase.
  • Balentine LLC's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $266K.
  • Balentine LLC fully exited Ventas in Q1 2017, selling an estimated $438K.
  • Balentine LLC's ten largest holdings make up 93% of its $1.02B portfolio in Q1 2017.
  • Balentine LLC opened 116 new positions and closed 36 in Q1 2017.
  • Balentine LLC's portfolio value rose 7.5% quarter-over-quarter to $1.02B.

Based on Balentine LLC's 13F filing for Q1 2017, filed 12 May 2017.